Short Interest in Option Care Health, Inc. (NASDAQ:OPCH) Drops By 34.8%

Option Care Health, Inc. (NASDAQ:OPCHGet Free Report) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totalling 3,800,000 shares, a decrease of 34.8% from the December 31st total of 5,830,000 shares. Based on an average daily trading volume, of 2,120,000 shares, the days-to-cover ratio is presently 1.8 days. Approximately 2.3% of the company’s shares are short sold.

Option Care Health Stock Down 1.9 %

NASDAQ OPCH opened at $30.83 on Wednesday. The company has a 50 day moving average of $24.62 and a 200-day moving average of $27.85. The company has a market cap of $5.25 billion, a price-to-earnings ratio of 25.91, a PEG ratio of 2.11 and a beta of 1.31. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on OPCH shares. JPMorgan Chase & Co. increased their price target on Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Truist Financial dropped their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Barrington Research raised their price objective on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 14th. Finally, Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $32.25.

View Our Latest Research Report on OPCH

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Company insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Institutional investors have recently modified their holdings of the business. Westfield Capital Management Co. LP grew its stake in shares of Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after purchasing an additional 599,589 shares during the last quarter. Global Alpha Capital Management Ltd. grew its stake in shares of Option Care Health by 108.3% in the third quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock worth $1,559,000 after purchasing an additional 25,905 shares during the last quarter. Graypoint LLC bought a new stake in shares of Option Care Health in the fourth quarter worth $1,161,000. Victory Capital Management Inc. grew its stake in shares of Option Care Health by 4,432.8% in the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after purchasing an additional 1,585,818 shares during the last quarter. Finally, Barclays PLC grew its stake in shares of Option Care Health by 180.1% in the third quarter. Barclays PLC now owns 310,194 shares of the company’s stock worth $9,708,000 after purchasing an additional 199,454 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Further Reading

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.